Skip to Content

Duramune Max PC

This page contains information on Duramune Max PC for veterinary use.
The information provided typically includes the following:
  • Duramune Max PC Indications
  • Warnings and cautions for Duramune Max PC
  • Direction and dosage information for Duramune Max PC

Duramune Max PC

This treatment applies to the following species:
Manufacturer: Boehringer Ingelheim

Canine Coronavirus-Parvovirus Vaccine

Modified Live and Killed Virus

For veterinary use only

For subcutaneous vaccination of healthy dogs 6 weeks of age or older as an aid in the prevention of disease caused by canine coronavirus and canine parvovirus (CPV). This product contains a CPV 2b strain which has been demonstrated to aid in the prevention of disease caused by CPV 2c in puppies with CPV maternal antibody.

Dose: Inject one 1 mL dose subcutaneously using aseptic technique. A recommended vaccination schedule should start at or about 6 weeks of age. The presence of maternal antibody is known to interfere with the development of active immunity. Puppies should be revaccinated every 2 to 3 weeks until they are at least 12 weeks of age. All dogs over 12 weeks of age should initially receive one dose of vaccine and a second dose 2 to 3 weeks later. Annual revaccination with one dose is recommended. Duration of immunity for CPV 2c has not been established.

The PEEL-OFF LABEL I.D. SYSTEM provides a simple and effective method of recording pertinent information on the vaccines administered to animals in a veterinary practice.

For vaccines requiring reconstitution, remove label from both vials and affix both labels to the animal’s medical chart.

Using the System:

1.

Grasp the vial label at the corner marked with an indicator arrow, between your thumb and forefinger (figure 1).

2.

Pull steadily at a slight angle until the label is separated from the vial (figure 2).

3.

Place the label on the animal’s medical chart. Press down on the label to ensure adhesion.

Duramune Max PC Caution

Store in the dark at 2° to 7°C (35° to 45°F). Avoid freezing. Shake well. In case of anaphylactoid reaction, administer epinephrine. Burn container and all unused contents.

Gentamicin and thimerosal added as preservatives.

Duramune Max PC Caution

In the absence of a veterinarian-client-patient relationship, Federal law prohibits the relabeling, repackaging, resale, or redistribution of the individual contents of this package.

Duramune® is a registered trademark of Boehringer Ingelheim Vetmedica, Inc.

© 2012 Boehringer Ingelheim Vetmedica, Inc. All rights reserved.

Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO 64506 U.S.A.

US Vet. Lic. No. 124

25 Doses

25 x 1 mL Vials of Vaccine

151305-00

CPN: 1028192.1

BOEHRINGER INGELHEIM VETMEDICA, INC.
2621 NORTH BELT HIGHWAY, ST. JOSEPH, MO, 64506-2002
Telephone:   800-325-9167
Fax:   816-236-2717
Website:   www.bevaccinesmart.com
    www.bi-vetmedica.com
    www.biviultraduramune.com
    www.bividollarsandsense.com
    www.bronchi-shieldoral.com
    www.duramunelepto.com
    www.duramunelyme.com
    www.haveweseenyourcatlately.com
    www.metacam.com
    www.mycathasdiabetes.com
    www.productionvalues.us
    www.prrsresearch.com
    www.prozinc.us
    www.vetera-vaccines.com
    www.vetmedin-us.com
    www.yourdogsheart.com
Email:   info@productionvalues.us
Every effort has been made to ensure the accuracy of the Duramune Max PC information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2017 North American Compendiums. Updated: 2017-01-09

Hide